Waltham, Massachusetts
United States
8
2023-07-27
8
2024-01-09
These are the the leading inventors for applications assigned to Xilio Development, Inc.:
Xilio Development, Inc. based in Waltham, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Masked IL-2-Fc fusion polypeptides
#2 | 2023-03-09 ✅ Patent 12,280,120 granted on 2025-04-22Tumor-specific cleavable linkers
#3 | 2023-02-02 ✅ Patent 11,827,685 granted on 2023-11-28Masked cytokine polypeptides
#4 | 2023-01-26 ✅ Patent 11,827,686 granted on 2023-11-28Masked cytokine polypeptides
#5 | 2022-09-29 ✅ Patent 11,718,655 granted on 2023-08-08Masked interleukin-12 polypeptides
#6 | 2022-03-10 ✅ Patent 12,384,845 granted on 2025-08-12ACTIVATABLE MASKED ANTI-CTLA4 BINDING PROTEINS
#7 | 2022-03-03 ✅ Patent 12,435,142 granted on 2025-10-07ANTI-CTLA4 ANTIBODIES AND METHODS OF USE THEREOF
#8 | 2021-01-07 ✅ Patent 11,053,294 granted on 2021-07-06Masked cytokine polypeptides
Also check out Xilio Development, Inc.'s (Waltham, United States) applicant profile with 13 patent applications submitted.
328811 ⎘